Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial
- 15 June 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 337 (8755), 1427-1431
- https://doi.org/10.1016/0140-6736(91)93124-r
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Platelets and the Beginnings of PreeclampsiaNew England Journal of Medicine, 1990
- Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertensionThe Lancet, 1990
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989
- The Use of Aspirin to Prevent Ppregnancy-Induced Hypertension and Lower the Ratio of Thromboxane A2to Prostcyclin in Relatively High Risk PregnanciesNew England Journal of Medicine, 1989
- Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiencyAmerican Journal of Obstetrics and Gynecology, 1988
- Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAEThe Lancet, 1986
- Preeclampsia: An imbalance in placental prostacyclin and thromboxane ProductionAmerican Journal of Obstetrics and Gynecology, 1985
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985